OrthoPediatrics Corp. filings document the regulatory record of a Nasdaq-listed medical device company focused on pediatric orthopedics. Its Form 8-K reports include quarterly and annual results, unaudited financial statements, revenue trends across Trauma and Deformity, Scoliosis, Sports Medicine/Other and OrthoPediatrics Specialty Bracing, as well as management guidance and investor presentation materials furnished under Regulation FD.
The company’s filings also cover governance and ownership matters through proxy statements, including board elections, executive compensation and equity awards. Material-event filings describe financing arrangements such as amendments to credit agreements and delayed draw term loan capacity, tying capital structure disclosures to the company’s operating and liquidity needs.
OrthoPediatrics Corp. (KIDS) has received Amendment No. 4 to a Schedule 13D from Squadron Capital LLC, Squadron Capital Holdings LLC, Jennifer N. Pritzker, and David R. Pelizzon updating their ownership in the company. Squadron Capital LLC now directly holds 6,201,764 shares of common stock, representing 23.8% of the outstanding shares based on 26,109,788 shares outstanding as of August 4, 2026. Including direct and indirect holdings, Jennifer N. Pritzker may be deemed to beneficially own 6,216,471 shares (23.8%), and David R. Pelizzon 6,246,148 shares (23.9%).
The filing also reports that Squadron Capital LLC sold 22,500 shares on September 2, 2026 at a weighted average price of $23.35 and 302,369 shares on September 10, 2026 at a weighted average price of $21.01, in each case to provide additional capital for its other portfolio businesses, while retaining a significant stake in OrthoPediatrics.
ORTHOPEDIATRICS CORP (KIDS) had a major shareholder, Squadron Capital LLC, report the sale of 302,369 shares of common stock on September 10, 2026, at a weighted average price of $21.01 per share, in multiple trades between $21.00 and $21.69. After this sale, Squadron Capital LLC reported holding 6,201,764 shares directly. The sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses, and no Rule 10b5-1 trading plan is reported. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
ORTHOPEDIATRICS CORP (KIDS) reported that major shareholder Jennifer N. Pritzker, through Squadron Capital LLC, sold 302,369 shares of common stock on September 10, 2026 at a weighted average price of $21.01 per share, in multiple trades between $21.00 and $21.69. A separate line shows Pritzker holding 10,900 shares directly after the reported date. The sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses, and Pritzker expressly disclaims beneficial ownership of Squadron’s shares except to the extent of her pecuniary interest.
ORTHOPEDIATRICS CORP (KIDS) reports that on September 10, 2026, 302,369 shares of common stock were sold in the open market by Squadron Capital LLC, an entity associated with director and ten percent owner David R. Pelizzon, at a weighted average price of $21.01 per share (range $21.00–$21.69). Following this sale, Squadron is reported with 6,201,764 indirectly held shares, while Pelizzon also holds 44,384 shares directly, including 17,959 restricted stock awards; he disclaims beneficial ownership of Squadron’s shares except to the extent of his pecuniary interest.
ORTHOPEDIATRICS CORP (KIDS) had a Form 4 filed for a large shareholder, Squadron Capital LLC, reporting a sale of 22,500 shares of Common Stock on September 2, 2026, at a weighted average price of $23.35 per share, in transactions ranging from $23.01 to $23.74. After this sale, Squadron Capital LLC reports holding 6,504,133 shares, which it holds directly, while Squadron Capital Holdings LLC is described as its controlling member. No Rule 10b5-1 trading plan is reported for this transaction, and a footnote states the sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
ORTHOPEDIATRICS CORP (KIDS) reported that on September 2, 2026, an entity associated with 10% owner Jennifer N. Pritzker, Squadron Capital LLC, sold 22,500 shares of common stock in a sale reported as an open market or private transaction at a weighted average price of $23.35 per share, with individual trade prices ranging from $23.01 to $23.74. The filing states this sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses and that no Rule 10b5-1 trading plan is reported.
After the reported transaction, Jennifer N. Pritzker is shown as holding 10,900 shares directly, and additional shares are held indirectly through Squadron Capital LLC, the Tawani Foundation, the Pritzker Military Foundation, the reporting person's spouse, and the Pritzker Military Museum and Library. For each of these indirect positions, she may be deemed the beneficial owner but expressly disclaims beneficial ownership of the shares, except to the extent of her pecuniary interest in them.
ORTHOPEDIATRICS CORP (KIDS) reported that director and ten percent owner David R. Pelizzon, through affiliated entity Squadron Capital LLC, indirectly sold 22,500 shares of common stock on September 2, 2026 at a weighted average price of $23.35 per share. The sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. After this transaction, entities associated with Pelizzon held 6,504,133 indirect shares and he held 44,384 shares directly, including 17,959 restricted stock awards, while he expressly disclaims beneficial ownership of Squadron’s shares except to the extent of his pecuniary interest.
ORTHOPEDIATRICS CORP (KIDS) reported that Squadron Capital LLC, a ten percent owner, sold a total of 336,831 shares of common stock in two open-market transactions. On August 28, 2026 it sold 326,700 shares at a weighted average price of $23.04 per share, with individual prices ranging from $23.00 to $23.82. On September 1, 2026 it sold 10,131 shares at a weighted average price of $23.10, with individual prices ranging from $23.00 to $23.58. The footnotes state the sale by Squadron Capital LLC was undertaken to provide additional capital for its other portfolio businesses, and that Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
OrthoPediatrics Corp. (KIDS) has an amended Schedule 13D (Amendment No. 3) reporting updated ownership and recent share sales by Squadron Capital LLC and related parties. Squadron Capital LLC directly holds 6,526,633 shares of common stock, representing 25.0% of the outstanding shares, based on 26,109,788 shares outstanding as of August 4, 2026.
Through direct and indirect holdings, Jennifer N. Pritzker is deemed to beneficially own 6,541,340 shares (about 25.1%), and David R. Pelizzon is deemed to beneficially own 6,571,017 shares (about 25.2%). Squadron Capital LLC executed several open-market sales between August 24 and September 1, 2026 at weighted average prices between $23.04 and $25.75, stated as undertaken to provide additional capital for its other portfolio businesses.
ORTHOPEDIATRICS CORP (KIDS) reported insider activity by ten percent owner Jennifer N. Pritzker, relating primarily to sales by Squadron Capital LLC, an entity with which she is associated. Squadron sold 326,700 shares of common stock on August 28, 2026 at a weighted average price of $23.04 per share (individual trades ranged from $23.00–$23.82), and later sold 10,131 shares on September 1, 2026 at a weighted average price of $23.10 (trades from $23.00–$23.58). The filing shows a separate direct holding of 10,900 shares of common stock for the reporting person as of August 28, 2026. For the indirect holdings, the reporting person may be deemed a beneficial owner through Squadron and several related foundations and entities but expressly disclaims beneficial ownership except to the extent of her pecuniary interest.